Systemic Immune Modulation in Gliomas: Prognostic Value of Plasma IL-6, YKL-40, and Genetic Variation in YKL-40

Por Camilla Bjørnbak Holst, Camilla Bjørnbak Holst, Camilla Bjørnbak Holst, Camilla Bjørnbak Holst, Ib Jarle Christensen, Jane Skjøth-Rasmussen, Petra Hamerlik, Hans Skovgaard Poulsen, Julia Sidenius Johansen, Julia Sidenius Johansen, Julia Sidenius Johansen
Publicado em 2020-04-01